Shares of Fuse Science Inc. (PINK: DROP), a development-stage company engaged in the development and maintenance of rights to sublingual and transdermal delivery systems of energy, medicines, vitamins and minerals to humans, surged in trading on Friday.
DROP shares ended the day 18.18% higher at $0.130 on volume of 1.14 million. Despite Friday’s gains, the stock fell 13.51% in the last three trading sessions.
Fuse Science recently provided an update to its shareholders and the investment community.
Fuse Science provided update in its capitalization efforts, GNC product distribution and the upcoming launch of its PowerFuse™ and ElectroFuse™ drop technologies.
Brian Tuffin, CEO of Fuse Science, said that the entire Fuse team remains focused and committed to the execution of a deliberate strategy that advances the development of its technology and consumer product offerings.
Recent Comments